Covid-19 Impact on Drug Discovery Informatics Market, Global Research Reports 2020-2021
This report covers market size and forecasts of Drug Discovery Informatics, including the following market information:
Major competitors identified in this market include IBM, Infosys, Thermo Fisher Scientific, Perkinelmer, Schr?dinger, Dassault Syst?mes, Charles River Laboratories, Selvita, Certara, GVK Biosciences, Collaborative Drug Discovery, Openeye Scientific Software, IO Informatics, Novo Informatics, etc.
Based on the Region:
- Global Drug Discovery Informatics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Drug Discovery Informatics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Drug Discovery Informatics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
- Global Drug Discovery Informatics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Major competitors identified in this market include IBM, Infosys, Thermo Fisher Scientific, Perkinelmer, Schr?dinger, Dassault Syst?mes, Charles River Laboratories, Selvita, Certara, GVK Biosciences, Collaborative Drug Discovery, Openeye Scientific Software, IO Informatics, Novo Informatics, etc.
Based on the Region:
- Asia-Pacific (China, Japan, South Korea, India and ASEAN)
- North America (US and Canada)
- Europe (Germany, France, UK and Italy)
- Rest of World (Latin America, Middle East & Africa)
- Software
- Services
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Others
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Drug Discovery Informatics Industry
1.7 COVID-19 Impact: Drug Discovery Informatics Market Trends
2 GLOBAL DRUG DISCOVERY INFORMATICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Drug Discovery Informatics Business Impact Assessment - COVID-19
2.1.1 Global Drug Discovery Informatics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Drug Discovery Informatics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Drug Discovery Informatics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Drug Discovery Informatics Headquarters and Area Served
3.3 Date of Key Players Enter into Drug Discovery Informatics Market
3.4 Key Players Drug Discovery Informatics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON DRUG DISCOVERY INFORMATICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Software
1.4.2 Services
4.2 By Type, Global Drug Discovery Informatics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON DRUG DISCOVERY INFORMATICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Pharmaceutical & Biotechnology Companies
5.5.2 Contract Research Organizations (CROs)
5.5.3 Others
5.2 By Application, Global Drug Discovery Informatics Market Size, 2019-2021
5.2.1 By Application, Global Drug Discovery Informatics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 IBM
7.1.1 IBM Business Overview
7.1.2 IBM Drug Discovery Informatics Quarterly Revenue, 2020
7.1.3 IBM Drug Discovery Informatics Product Introduction
7.1.4 IBM Response to COVID-19 and Related Developments
7.2 Infosys
7.2.1 Infosys Business Overview
7.2.2 Infosys Drug Discovery Informatics Quarterly Revenue, 2020
7.2.3 Infosys Drug Discovery Informatics Product Introduction
7.2.4 Infosys Response to COVID-19 and Related Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Business Overview
7.3.2 Thermo Fisher Scientific Drug Discovery Informatics Quarterly Revenue, 2020
7.3.3 Thermo Fisher Scientific Drug Discovery Informatics Product Introduction
7.3.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.4 Perkinelmer
7.4.1 Perkinelmer Business Overview
7.4.2 Perkinelmer Drug Discovery Informatics Quarterly Revenue, 2020
7.4.3 Perkinelmer Drug Discovery Informatics Product Introduction
7.4.4 Perkinelmer Response to COVID-19 and Related Developments
7.5 Schr?dinger
7.5.1 Schr?dinger Business Overview
7.5.2 Schr?dinger Drug Discovery Informatics Quarterly Revenue, 2020
7.5.3 Schr?dinger Drug Discovery Informatics Product Introduction
7.5.4 Schr?dinger Response to COVID-19 and Related Developments
7.6 Dassault Syst?mes
7.6.1 Dassault Syst?mes Business Overview
7.6.2 Dassault Syst?mes Drug Discovery Informatics Quarterly Revenue, 2020
7.6.3 Dassault Syst?mes Drug Discovery Informatics Product Introduction
7.6.4 Dassault Syst?mes Response to COVID-19 and Related Developments
7.7 Charles River Laboratories
7.7.1 Charles River Laboratories Business Overview
7.7.2 Charles River Laboratories Drug Discovery Informatics Quarterly Revenue, 2020
7.7.3 Charles River Laboratories Drug Discovery Informatics Product Introduction
7.7.4 Charles River Laboratories Response to COVID-19 and Related Developments
7.8 Selvita
7.8.1 Selvita Business Overview
7.8.2 Selvita Drug Discovery Informatics Quarterly Revenue, 2020
7.8.3 Selvita Drug Discovery Informatics Product Introduction
7.8.4 Selvita Response to COVID-19 and Related Developments
7.9 Certara
7.9.1 Certara Business Overview
7.9.2 Certara Drug Discovery Informatics Quarterly Revenue, 2020
7.9.3 Certara Drug Discovery Informatics Product Introduction
7.9.4 Certara Response to COVID-19 and Related Developments
7.10 GVK Biosciences
7.10.1 GVK Biosciences Business Overview
7.10.2 GVK Biosciences Drug Discovery Informatics Quarterly Revenue, 2020
7.10.3 GVK Biosciences Drug Discovery Informatics Product Introduction
7.10.4 GVK Biosciences Response to COVID-19 and Related Developments
7.11 Collaborative Drug Discovery
7.11.1 Collaborative Drug Discovery Business Overview
7.11.2 Collaborative Drug Discovery Drug Discovery Informatics Quarterly Revenue, 2020
7.11.3 Collaborative Drug Discovery Drug Discovery Informatics Product Introduction
7.11.4 Collaborative Drug Discovery Response to COVID-19 and Related Developments
7.12 Openeye Scientific Software
7.12.1 Openeye Scientific Software Business Overview
7.12.2 Openeye Scientific Software Drug Discovery Informatics Quarterly Revenue, 2020
7.12.3 Openeye Scientific Software Drug Discovery Informatics Product Introduction
7.12.4 Openeye Scientific Software Response to COVID-19 and Related Developments
7.13 IO Informatics
7.13.1 IO Informatics Business Overview
7.13.2 IO Informatics Drug Discovery Informatics Quarterly Revenue, 2020
7.13.3 IO Informatics Drug Discovery Informatics Product Introduction
7.13.4 IO Informatics Response to COVID-19 and Related Developments
7.14 Novo Informatics
7.14.1 Novo Informatics Business Overview
7.14.2 Novo Informatics Drug Discovery Informatics Quarterly Revenue, 2020
7.14.3 Novo Informatics Drug Discovery Informatics Product Introduction
7.14.4 Novo Informatics Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Drug Discovery Informatics Industry
1.7 COVID-19 Impact: Drug Discovery Informatics Market Trends
2 GLOBAL DRUG DISCOVERY INFORMATICS QUARTERLY MARKET SIZE ANALYSIS
2.1 Drug Discovery Informatics Business Impact Assessment - COVID-19
2.1.1 Global Drug Discovery Informatics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Drug Discovery Informatics Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 QUARTERLY COMPETITIVE ASSESSMENT, 2020
3.1 By Players, Global Drug Discovery Informatics Quarterly Market Size, 2019 VS 2020
3.2 By Players, Drug Discovery Informatics Headquarters and Area Served
3.3 Date of Key Players Enter into Drug Discovery Informatics Market
3.4 Key Players Drug Discovery Informatics Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 IMPACT OF COVID-19 ON DRUG DISCOVERY INFORMATICS SEGMENTS, BY TYPE
4.1 Introduction
1.4.1 Software
1.4.2 Services
4.2 By Type, Global Drug Discovery Informatics Market Size, 2019-2021
5 IMPACT OF COVID-19 ON DRUG DISCOVERY INFORMATICS SEGMENTS, BY APPLICATION
5.1 Overview
5.5.1 Pharmaceutical & Biotechnology Companies
5.5.2 Contract Research Organizations (CROs)
5.5.3 Others
5.2 By Application, Global Drug Discovery Informatics Market Size, 2019-2021
5.2.1 By Application, Global Drug Discovery Informatics Market Size by Application, 2019-2021
6 GEOGRAPHIC ANALYSIS
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 COMPANY PROFILES
7.1 IBM
7.1.1 IBM Business Overview
7.1.2 IBM Drug Discovery Informatics Quarterly Revenue, 2020
7.1.3 IBM Drug Discovery Informatics Product Introduction
7.1.4 IBM Response to COVID-19 and Related Developments
7.2 Infosys
7.2.1 Infosys Business Overview
7.2.2 Infosys Drug Discovery Informatics Quarterly Revenue, 2020
7.2.3 Infosys Drug Discovery Informatics Product Introduction
7.2.4 Infosys Response to COVID-19 and Related Developments
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Business Overview
7.3.2 Thermo Fisher Scientific Drug Discovery Informatics Quarterly Revenue, 2020
7.3.3 Thermo Fisher Scientific Drug Discovery Informatics Product Introduction
7.3.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
7.4 Perkinelmer
7.4.1 Perkinelmer Business Overview
7.4.2 Perkinelmer Drug Discovery Informatics Quarterly Revenue, 2020
7.4.3 Perkinelmer Drug Discovery Informatics Product Introduction
7.4.4 Perkinelmer Response to COVID-19 and Related Developments
7.5 Schr?dinger
7.5.1 Schr?dinger Business Overview
7.5.2 Schr?dinger Drug Discovery Informatics Quarterly Revenue, 2020
7.5.3 Schr?dinger Drug Discovery Informatics Product Introduction
7.5.4 Schr?dinger Response to COVID-19 and Related Developments
7.6 Dassault Syst?mes
7.6.1 Dassault Syst?mes Business Overview
7.6.2 Dassault Syst?mes Drug Discovery Informatics Quarterly Revenue, 2020
7.6.3 Dassault Syst?mes Drug Discovery Informatics Product Introduction
7.6.4 Dassault Syst?mes Response to COVID-19 and Related Developments
7.7 Charles River Laboratories
7.7.1 Charles River Laboratories Business Overview
7.7.2 Charles River Laboratories Drug Discovery Informatics Quarterly Revenue, 2020
7.7.3 Charles River Laboratories Drug Discovery Informatics Product Introduction
7.7.4 Charles River Laboratories Response to COVID-19 and Related Developments
7.8 Selvita
7.8.1 Selvita Business Overview
7.8.2 Selvita Drug Discovery Informatics Quarterly Revenue, 2020
7.8.3 Selvita Drug Discovery Informatics Product Introduction
7.8.4 Selvita Response to COVID-19 and Related Developments
7.9 Certara
7.9.1 Certara Business Overview
7.9.2 Certara Drug Discovery Informatics Quarterly Revenue, 2020
7.9.3 Certara Drug Discovery Informatics Product Introduction
7.9.4 Certara Response to COVID-19 and Related Developments
7.10 GVK Biosciences
7.10.1 GVK Biosciences Business Overview
7.10.2 GVK Biosciences Drug Discovery Informatics Quarterly Revenue, 2020
7.10.3 GVK Biosciences Drug Discovery Informatics Product Introduction
7.10.4 GVK Biosciences Response to COVID-19 and Related Developments
7.11 Collaborative Drug Discovery
7.11.1 Collaborative Drug Discovery Business Overview
7.11.2 Collaborative Drug Discovery Drug Discovery Informatics Quarterly Revenue, 2020
7.11.3 Collaborative Drug Discovery Drug Discovery Informatics Product Introduction
7.11.4 Collaborative Drug Discovery Response to COVID-19 and Related Developments
7.12 Openeye Scientific Software
7.12.1 Openeye Scientific Software Business Overview
7.12.2 Openeye Scientific Software Drug Discovery Informatics Quarterly Revenue, 2020
7.12.3 Openeye Scientific Software Drug Discovery Informatics Product Introduction
7.12.4 Openeye Scientific Software Response to COVID-19 and Related Developments
7.13 IO Informatics
7.13.1 IO Informatics Business Overview
7.13.2 IO Informatics Drug Discovery Informatics Quarterly Revenue, 2020
7.13.3 IO Informatics Drug Discovery Informatics Product Introduction
7.13.4 IO Informatics Response to COVID-19 and Related Developments
7.14 Novo Informatics
7.14.1 Novo Informatics Business Overview
7.14.2 Novo Informatics Drug Discovery Informatics Quarterly Revenue, 2020
7.14.3 Novo Informatics Drug Discovery Informatics Product Introduction
7.14.4 Novo Informatics Response to COVID-19 and Related Developments
8 KEY FINDINGS
9 APPENDIX
9.1 About US
9.2 Disclaimer
LIST OF TABLES
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Drug Discovery Informatics Assessment
Table 9. COVID-19 Impact: Drug Discovery Informatics Market Trends
Table 10. COVID-19 Impact Global Drug Discovery Informatics Market Size
Table 11. Global Drug Discovery Informatics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Drug Discovery Informatics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Drug Discovery Informatics Market Growth Drivers
Table 14. Global Drug Discovery Informatics Market Restraints
Table 15. Global Drug Discovery Informatics Market Opportunities
Table 16. Global Drug Discovery Informatics Market Challenges
Table 17. By Players, Drug Discovery Informatics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Drug Discovery Informatics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Drug Discovery Informatics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Drug Discovery Informatics Market
Table 21. Key Players Drug Discovery Informatics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Drug Discovery Informatics Market Size 2019-2021, (US$ Million)
Table 24. Global Drug Discovery Informatics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Drug Discovery Informatics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 57. IBM Business Overview
Table 58. IBM Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. IBM Drug Discovery Informatics Product
Table 60. IBM Response to COVID-19 and Related Developments
Table 61. Infosys Business Overview
Table 62. Infosys Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Infosys Drug Discovery Informatics Product
Table 64. Infosys Response to COVID-19 and Related Developments
Table 65. Thermo Fisher Scientific Business Overview
Table 66. Thermo Fisher Scientific Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Thermo Fisher Scientific Drug Discovery Informatics Product
Table 68. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 69. Perkinelmer Business Overview
Table 70. Perkinelmer Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Perkinelmer Drug Discovery Informatics Product
Table 72. Perkinelmer Response to COVID-19 and Related Developments
Table 73. Schr?dinger Business Overview
Table 74. Schr?dinger Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Schr?dinger Drug Discovery Informatics Product
Table 76. Schr?dinger Response to COVID-19 and Related Developments
Table 77. Dassault Syst?mes Business Overview
Table 78. Dassault Syst?mes Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Dassault Syst?mes Drug Discovery Informatics Product
Table 80. Dassault Syst?mes Response to COVID-19 and Related Developments
Table 81. Charles River Laboratories Business Overview
Table 82. Charles River Laboratories Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Charles River Laboratories Drug Discovery Informatics Product
Table 84. Charles River Laboratories Response to COVID-19 and Related Developments
Table 85. Selvita Business Overview
Table 86. Selvita Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Selvita Drug Discovery Informatics Product
Table 88. Selvita Response to COVID-19 and Related Developments
Table 89. Certara Business Overview
Table 90. Certara Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Certara Drug Discovery Informatics Product
Table 92. Certara Response to COVID-19 and Related Developments
Table 93. GVK Biosciences Business Overview
Table 94. GVK Biosciences Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. GVK Biosciences Drug Discovery Informatics Product
Table 96. GVK Biosciences Response to COVID-19 and Related Developments
Table 97. Collaborative Drug Discovery Business Overview
Table 98. Collaborative Drug Discovery Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Collaborative Drug Discovery Drug Discovery Informatics Product
Table 100. Collaborative Drug Discovery Response to COVID-19 and Related Developments
Table 101. Openeye Scientific Software Business Overview
Table 102. Openeye Scientific Software Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Openeye Scientific Software Drug Discovery Informatics Product
Table 104. Openeye Scientific Software Response to COVID-19 and Related Developments
Table 105. IO Informatics Business Overview
Table 106. IO Informatics Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. IO Informatics Drug Discovery Informatics Product
Table 108. IO Informatics Response to COVID-19 and Related Developments
Table 109. Novo Informatics Business Overview
Table 110. Novo Informatics Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Novo Informatics Drug Discovery Informatics Product
Table 112. Novo Informatics Response to COVID-19 and Related Developments
Table 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Drug Discovery Informatics Assessment
Table 9. COVID-19 Impact: Drug Discovery Informatics Market Trends
Table 10. COVID-19 Impact Global Drug Discovery Informatics Market Size
Table 11. Global Drug Discovery Informatics Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Drug Discovery Informatics Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Drug Discovery Informatics Market Growth Drivers
Table 14. Global Drug Discovery Informatics Market Restraints
Table 15. Global Drug Discovery Informatics Market Opportunities
Table 16. Global Drug Discovery Informatics Market Challenges
Table 17. By Players, Drug Discovery Informatics Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Drug Discovery Informatics Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Drug Discovery Informatics Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Drug Discovery Informatics Market
Table 21. Key Players Drug Discovery Informatics Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Drug Discovery Informatics Market Size 2019-2021, (US$ Million)
Table 24. Global Drug Discovery Informatics Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Drug Discovery Informatics Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Drug Discovery Informatics Market Size, 2019-2021 (US$ Million)
Table 57. IBM Business Overview
Table 58. IBM Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. IBM Drug Discovery Informatics Product
Table 60. IBM Response to COVID-19 and Related Developments
Table 61. Infosys Business Overview
Table 62. Infosys Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Infosys Drug Discovery Informatics Product
Table 64. Infosys Response to COVID-19 and Related Developments
Table 65. Thermo Fisher Scientific Business Overview
Table 66. Thermo Fisher Scientific Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Thermo Fisher Scientific Drug Discovery Informatics Product
Table 68. Thermo Fisher Scientific Response to COVID-19 and Related Developments
Table 69. Perkinelmer Business Overview
Table 70. Perkinelmer Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Perkinelmer Drug Discovery Informatics Product
Table 72. Perkinelmer Response to COVID-19 and Related Developments
Table 73. Schr?dinger Business Overview
Table 74. Schr?dinger Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Schr?dinger Drug Discovery Informatics Product
Table 76. Schr?dinger Response to COVID-19 and Related Developments
Table 77. Dassault Syst?mes Business Overview
Table 78. Dassault Syst?mes Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Dassault Syst?mes Drug Discovery Informatics Product
Table 80. Dassault Syst?mes Response to COVID-19 and Related Developments
Table 81. Charles River Laboratories Business Overview
Table 82. Charles River Laboratories Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. Charles River Laboratories Drug Discovery Informatics Product
Table 84. Charles River Laboratories Response to COVID-19 and Related Developments
Table 85. Selvita Business Overview
Table 86. Selvita Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Selvita Drug Discovery Informatics Product
Table 88. Selvita Response to COVID-19 and Related Developments
Table 89. Certara Business Overview
Table 90. Certara Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Certara Drug Discovery Informatics Product
Table 92. Certara Response to COVID-19 and Related Developments
Table 93. GVK Biosciences Business Overview
Table 94. GVK Biosciences Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. GVK Biosciences Drug Discovery Informatics Product
Table 96. GVK Biosciences Response to COVID-19 and Related Developments
Table 97. Collaborative Drug Discovery Business Overview
Table 98. Collaborative Drug Discovery Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Collaborative Drug Discovery Drug Discovery Informatics Product
Table 100. Collaborative Drug Discovery Response to COVID-19 and Related Developments
Table 101. Openeye Scientific Software Business Overview
Table 102. Openeye Scientific Software Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Openeye Scientific Software Drug Discovery Informatics Product
Table 104. Openeye Scientific Software Response to COVID-19 and Related Developments
Table 105. IO Informatics Business Overview
Table 106. IO Informatics Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. IO Informatics Drug Discovery Informatics Product
Table 108. IO Informatics Response to COVID-19 and Related Developments
Table 109. Novo Informatics Business Overview
Table 110. Novo Informatics Drug Discovery Informatics Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 111. Novo Informatics Drug Discovery Informatics Product
Table 112. Novo Informatics Response to COVID-19 and Related Developments
LIST OF FIGURES
Figure 1. Drug Discovery Informatics Product Picture
Figure 2. Drug Discovery Informatics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Drug Discovery Informatics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Drug Discovery Informatics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Drug Discovery Informatics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Drug Discovery Informatics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Drug Discovery Informatics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Drug Discovery Informatics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Drug Discovery Informatics Market Size Market Share, 2019-2021
Figure 1. Drug Discovery Informatics Product Picture
Figure 2. Drug Discovery Informatics Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Drug Discovery Informatics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Drug Discovery Informatics Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Drug Discovery Informatics Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Drug Discovery Informatics Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Drug Discovery Informatics Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Drug Discovery Informatics Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Drug Discovery Informatics Market Size Market Share, 2019-2021
